--- title: "Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital" type: "News" locale: "en" url: "https://longbridge.com/en/news/296223201.md" description: "BMO Capital analyst Evan Seigerman maintained a Buy rating on Vertex Pharmaceuticals (VRTX) with a $600 price target, up from the current close of $515.55. The broader analyst consensus remains a Strong Buy with an average target of $565.32, implying 9.65% upside. Additionally, RBC Capital recently reiterated a Buy rating with a $570 target." datetime: "2026-08-18T11:37:46.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296223201.md) - [en](https://longbridge.com/en/news/296223201.md) - [zh-HK](https://longbridge.com/zh-HK/news/296223201.md) generator: "portal-rs" --- # Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital BMO Capital analyst Evan Seigerman maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $600.00. The company’s shares closed yesterday at $515.55. ### Summer Sale - Claim 70% Off TipRanks - Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions - Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks Seigerman covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Novo Nordisk, and Pfizer. According to TipRanks, Seigerman has an average return of 10.7% and a 59.19% success rate on recommended stocks. Currently, the analyst consensus on Vertex Pharmaceuticals is a Strong Buy with an average price target of $565.32, implying a 9.65% upside from current levels. In a report released on August 12, RBC Capital also maintained a Buy rating on the stock with a $570.00 price target. ### Related Stocks - [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md) - [BMO.US](https://longbridge.com/en/quote/BMO.US.md) - [LLY.US](https://longbridge.com/en/quote/LLY.US.md) - [NVO.US](https://longbridge.com/en/quote/NVO.US.md) - [PFE.US](https://longbridge.com/en/quote/PFE.US.md) - [RY.US](https://longbridge.com/en/quote/RY.US.md) ## Related News & Research - [Are Wall Street Analysts Bullish on Vertex Stock?](https://longbridge.com/en/news/296449653.md) - [Callan Family Office LLC Buys New Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296677120.md) - [Clal Insurance Enterprises Holdings Ltd Buys Shares of 2,019 Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296756674.md) - [The Bull Case For Vertex (VRTX) Could Change Following Upgraded 2026 Guidance And Pipeline Momentum - Learn Why](https://longbridge.com/en/news/296583461.md) - [Osmosis Investment Management UK Ltd Acquires Shares of 21,075 Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296771760.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**